Business
CaliPharms Provides Shareholder Update
CaliPharms Provides Shareholder Update.
About this update from Kleangas Energy Technologies Inc
[{"type":"text","content":"CaliPharms, Inc. (OTCPink: KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol \"KGET\" provides the following shareholder update.The company continues to explore acquisition opportunities in the medical cannabis sectors as well as other sectors. Several target acquisitions have been presented to KGET and management is working to find the best fit for the company.KGET President Bo Linton stated, “At this point it appears that KGET is not a good fit for the Amazon delivery opportunity but we have formed a solid relationship with its founders and new opportunities with them could emerge. For now we will stay focused on the best acquisition targets for KGET and its shareholders.”About CaliPharms, Inc. CaliPharms Inc., trading under the symbol (KGET) which trades under its former name Kleangas Energy Technologies, Inc. is a development stage business. The Company currently is focused on an acquisition within the Last Mile Delivery sector.Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as CaliPharms or KGET or its management \"believes,\" \"expects,\" \"anticipates,\" \"foresees,\" \"forecasts,\" \"estimates\" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Investment into a microcap company is a high risk investment and it should only be considered if you are able to afford a total loss of the investment. Laws and Regulations of Marijuana are currently in direct contradiction between California and Federal Law and these factors should be a part of your consideration when making an investment into KGET.Company Contact: CaliPharms, Inc. (KGET)www.CaliPharmsInc.comfacebook.com/CaliPharmstwitter.com/CaliPharmsTelephone 1-949-800-6645Email: [email protected]","length":2769,"tagName":"div"}]